New Reagent

The search engine found new reagents in the following categories.




SARS-CoV-2

Showing 1 to 20 of 40 Results12
BEI NumberDescriptionLevelReleased DateDescending Order
NRH-21756 Pooled Human Serum Sample, Novavax Vaccine (1.0 mL) BEI Level 2 June 2022
NR-56132 Spike Glycoprotein (Stabilized) from SARS-Related Coronavirus 2, with C-Terminal Histidine and Twin-Strep® Tags, Recombinant from HEK293F Cells SARS-Related Coronavirus 2 BEI Level 1 June 2022
NR-56134 Spike Glycoprotein (Stabilized) from Human Coronavirus NL63, with C-Terminal Histidine and Twin-Strep® Tags, Recombinant from HEK293 Cells Human Coronavirus BEI Level 1 June 2022
NR-56519 SARS-Related Coronavirus 2 Isolate hCoV-19/USA/VA-FBCH_675/2021 (Lineage AY4.2; Delta Variant) BEI Level 3 June 2022
NR-54980 Modified pαH Vector Containing the Middle East Respiratory Syndrome Coronavirus Spike Glycoprotein Middle East Respiratory Syndrome Coronavirus BEI Level 1 June 2022
NR-54978 Modified pαH Vector Containing the Human Coronavirus, HKU1 Spike Glycoprotein Human Coronavirus BEI Level 1 June 2022
NR-56781 SARS-Related Coronavirus 2 Isolate hCoV-19/USA/NY-MSHSPSP-PV56475/2022 (Lineage BA.2.12.1; Omicron Variant) BEI Level 3 June 2022
NR-56699 SARS-Related Coronavirus 2 Isolate hCoV-19/France/PAC-IHUMI-6070/2022 p2 (Lineage AY.4 plus Omicron; XD Variant) BEI Level 3 June 2022
NR-54979 Modified pαH Vector Containing the Human Coronavirus, OC43 Spike Glycoprotein Human Coronavirus BEI Level 1 May 2022
NR-56695 SARS-Related Coronavirus 2 Isolate hCoV-19/France/PAC-IHUMI-6070/2022 (Lineage AY.4 plus omicron; XD Variant) BEI Level 3 May 2022
NR-55303 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP2F2 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55302 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP2E7 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55301 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP2C7 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55300 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP2C2 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55299 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP1F2 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55298 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP1E6 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55297 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP1D10 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55296 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP1C3 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NR-55295 Monoclonal Anti-SARS-Related Coronavirus 2 Spike Glycoprotein Receptor Binding Domain (RBD), Clone 2TP1B11 (produced in vitro) SARS-Related Coronavirus 2 BEI Level 1 May 2022
NRH-21747 Pooled Human Serum Sample, Moderna Vaccine BEI Level 2 May 2022
Showing 1 to 20 of 40 Results12